We are not patients, we are not families, we are not doctors…but we live with rare diseases, we think rare diseases…we are researchers, we are APTEEUS!
APTEEUS has been awarded at the France Tech Transfer Invest 2019. France Tech Transfer Invest 2019 took place on 13-14 February 2019 in Paris, organised by Tech Tour and hosted by Bpifrance, France’s National Development Bank and innovation agency, in collaboration with five French Government bodies: SATT, CEA, CNRS, Inria and Inserm-Transfert. The 3rd edition..
Apteeus has started a tailor-made research program for the association Les Petits Mec P2. Less than 18 months after the first exchanges with the association and opinion leaders in the field, several thousand molecules for human use were tested on the cells of Sacha, a child suffering from MeCP2 gene duplication syndrome. We have identified..
Rare Disease 360°, Collaborative Strategies to leave no-one behind Proud to present the high potential of APTEEUS Protein Re-expression Therapy, Isabelle will attend the European Conference on Rare Diseases and Orphan Products in Vienne. SHe will also expose the innovative way APTEEUS and Les Petits MeCP2 association are collaborating.
Camille, Isabelle, Loïc, Simon, Benoit and Terence wish you all the best for 2018.